Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex - PubMed (original) (raw)
Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex
Alina Tuganova et al. Biochem J. 2002.
Abstract
Protein-protein interactions play an important role in the regulation of enzymic activity of pyruvate dehydrogenase kinase (PDK). It is generally believed that the binding of PDK to the inner lipoyl-bearing domain L2 of the transacetylase component E2 of pyruvate dehydrogenase complex largely determines the level of kinase activity. In the present study, we characterized the interaction between the individual isoenzymes of PDK (PDK1-PDK4) and monomeric L2 domain of human E2, as well as the effect of this interaction on kinase activity. It was found that PDK isoenzymes are markedly different with respect to their affinities for L2. PDK3 demonstrated a very tight binding, which persisted during isolation of PDK3-L2 complexes using size-exclusion chromatography. Binding of PDK1 and PDK2 was readily reversible with the apparent dissociation constant of approx. 10 microM for both isoenzymes. PDK4 had a greatly reduced capacity for L2 binding (relative order PDK3>PDK1=PDK2>PDK4). Monomeric L2 domain alone had very little effect on the activities of either PDK1 or PDK2. In contrast, L2 caused a 3-fold increase in PDK3 activity and approx. 37% increase in PDK4 activity. These results strongly suggest that the interactions between the individual isoenzymes of PDK and L2 domain are isoenzyme-specific and might be among the major factors that determine the level of kinase activity of particular isoenzyme towards the pyruvate dehydrogenase complex.
Similar articles
- The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.
Klyuyeva A, Tuganova A, Popov KM. Klyuyeva A, et al. Biochemistry. 2005 Oct 18;44(41):13573-82. doi: 10.1021/bi0505868. Biochemistry. 2005. PMID: 16216081 Free PMC article. - Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.
Kolobova E, Tuganova A, Boulatnikov I, Popov KM. Kolobova E, et al. Biochem J. 2001 Aug 15;358(Pt 1):69-77. doi: 10.1042/0264-6021:3580069. Biochem J. 2001. PMID: 11485553 Free PMC article. - Marked differences between two isoforms of human pyruvate dehydrogenase kinase.
Baker JC, Yan X, Peng T, Kasten S, Roche TE. Baker JC, et al. J Biol Chem. 2000 May 26;275(21):15773-81. doi: 10.1074/jbc.M909488199. J Biol Chem. 2000. PMID: 10748134 - Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.
Roche TE, Hiromasa Y. Roche TE, et al. Cell Mol Life Sci. 2007 Apr;64(7-8):830-49. doi: 10.1007/s00018-007-6380-z. Cell Mol Life Sci. 2007. PMID: 17310282 Free PMC article. Review. - Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
Sugden MC, Holness MJ. Sugden MC, et al. Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476789 Review.
Cited by
- Biphasic Dynamics of Macrophage Immunometabolism during Mycobacterium tuberculosis Infection.
Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S. Shi L, et al. mBio. 2019 Mar 26;10(2):e02550-18. doi: 10.1128/mBio.02550-18. mBio. 2019. PMID: 30914513 Free PMC article. Review. - Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.
Li J, Kato M, Chuang DT. Li J, et al. J Biol Chem. 2009 Dec 4;284(49):34458-67. doi: 10.1074/jbc.M109.065557. Epub 2009 Oct 15. J Biol Chem. 2009. PMID: 19833728 Free PMC article. - Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.
Kato M, Chuang JL, Tso SC, Wynn RM, Chuang DT. Kato M, et al. EMBO J. 2005 May 18;24(10):1763-74. doi: 10.1038/sj.emboj.7600663. Epub 2005 Apr 28. EMBO J. 2005. PMID: 15861126 Free PMC article. - The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.
Klyuyeva A, Tuganova A, Popov KM. Klyuyeva A, et al. Biochemistry. 2005 Oct 18;44(41):13573-82. doi: 10.1021/bi0505868. Biochemistry. 2005. PMID: 16216081 Free PMC article. - Regulation of pyruvate metabolism and human disease.
Gray LR, Tompkins SC, Taylor EB. Gray LR, et al. Cell Mol Life Sci. 2014 Jul;71(14):2577-604. doi: 10.1007/s00018-013-1539-2. Epub 2013 Dec 21. Cell Mol Life Sci. 2014. PMID: 24363178 Free PMC article. Review.
References
- Arch Biochem Biophys. 1972 Jul;151(1):328-40 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Biochem Biophys Res Commun. 1975 Jul 22;65(2):575-82 - PubMed
- Nature. 1975 Oct 30;257(5529):808-9 - PubMed
- Biochem Biophys Res Commun. 1977 Apr 11;75(3):541-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous